MedPath

Tamparin

Brand Name: Tamparin

Generic Name: Enoxaparin sodium

Active
Registration Number

BRP-040-08

Dosage Form

Solution For Injection

Issuance Date

March 31, 2025

Expiry Date

March 31, 2037

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength6000 IU anti-factor Xa (equivalent to 60 mg) / 0.6 mL
Packaging0.6 mL in 1 mL Pre-filled Syringe (Box of 1 Blister Pack)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antithrombotic Agents
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Enoxaparin sodiumActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform